US1140822099

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

February 20, 2026 09:05 ET  | Source: Ernexa Therapeutics Inc. Live video webcast with Sanjeev Luther, President and Chief Executive…

5 days ago

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

February 06, 2026 09:25 ET  | Source: Ernexa Therapeutics Inc. CAMBRIDGE, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics…

2 weeks ago

Ernexa Therapeutics to Present at Oxford Globals Cell 2025

Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussion November 11, 2025…

4 months ago